Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: Case report and review of literature

Thalidomide is being increasingly used in hematology and oncology. Its use is associated with neuropathy, sedation, edema, fatigue, constipation, and deep venous thrombosis. Cytopenias are unusual, but there are case reports. However, there are no reports of isolated thrombocytopenia. We describe he...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hematology 2007-09, Vol.82 (9), p.855-857
Hauptverfasser: Prasad, H. Keshava, Kaushal, Varsha, Mehta, Paulette
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 857
container_issue 9
container_start_page 855
container_title American journal of hematology
container_volume 82
creator Prasad, H. Keshava
Kaushal, Varsha
Mehta, Paulette
description Thalidomide is being increasingly used in hematology and oncology. Its use is associated with neuropathy, sedation, edema, fatigue, constipation, and deep venous thrombosis. Cytopenias are unusual, but there are case reports. However, there are no reports of isolated thrombocytopenia. We describe here a case of prolonged isolated thrombocytopenia most likely caused by thalidomide. The patient's in platelet count decreased promptly after an increase in the dose and improved after discontinuation of the drug. The relevant literature is reviewed. Am. J. Hematol., 2007. © 2007 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ajh.20949
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ajh_20949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AJH20949</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3039-d0be14409648f8d592ee7a0df03447442ddeaece0e538be12ec4f538cf6b35a13</originalsourceid><addsrcrecordid>eNp10MFu3CAQBmBUNWq2aQ95gYhLDz1sMhjsNblFq7ZJFSmX5GyNYawlwsYCNiu_fWl3pZx64hfziRE_Y5cCrgVAdYOvu-sKtNIf2EqAbtZtU1cf2QpkI0oGfc4-p_QKIIRq4RM7F5t6A7WAFVseUvCYyfK8i2Hsg1lymGlyyN1k96YM-qXM0DsbRmepXHPkM2ZHU-YHl3d83PvsZk98XMiHEW_5FhPxSHOImeNkS3xzdOBh4N5lipj3kb6wswF9oq-n84K9_PzxvL1fPz79etjePa6NBKnXFnoSSpVfqXZoba0rog2CHUAqtVGqspaQDAHVsi20IqOGEs3Q9LJGIS_Y9-O7JoaUIg3dHN2IcekEdH_r60p93b_6ir062nnfj2Tf5amvAr6dACaDfog4GZfeXau1lLop7uboDs7T8v-N3d3v--PqPw-CiSE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: Case report and review of literature</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Wiley Free Content</source><creator>Prasad, H. Keshava ; Kaushal, Varsha ; Mehta, Paulette</creator><creatorcontrib>Prasad, H. Keshava ; Kaushal, Varsha ; Mehta, Paulette</creatorcontrib><description>Thalidomide is being increasingly used in hematology and oncology. Its use is associated with neuropathy, sedation, edema, fatigue, constipation, and deep venous thrombosis. Cytopenias are unusual, but there are case reports. However, there are no reports of isolated thrombocytopenia. We describe here a case of prolonged isolated thrombocytopenia most likely caused by thalidomide. The patient's in platelet count decreased promptly after an increase in the dose and improved after discontinuation of the drug. The relevant literature is reviewed. Am. J. Hematol., 2007. © 2007 Wiley‐Liss, Inc.</description><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.20949</identifier><identifier>PMID: 17570510</identifier><identifier>CODEN: AJHEDD</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Dose-Response Relationship, Drug ; Hematologic and hematopoietic diseases ; Humans ; Immunodeficiencies. Immunoglobulinopathies ; Immunoglobulinopathies ; Immunopathology ; Medical sciences ; Middle Aged ; Multiple Myeloma - blood ; Multiple Myeloma - drug therapy ; Platelet Count ; Platelet diseases and coagulopathies ; Thalidomide - adverse effects ; Thrombocytopenia - chemically induced ; Treatment Outcome</subject><ispartof>American journal of hematology, 2007-09, Vol.82 (9), p.855-857</ispartof><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><rights>2007 INIST-CNRS</rights><rights>2007 Wiley-Liss, Inc</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3039-d0be14409648f8d592ee7a0df03447442ddeaece0e538be12ec4f538cf6b35a13</citedby><cites>FETCH-LOGICAL-c3039-d0be14409648f8d592ee7a0df03447442ddeaece0e538be12ec4f538cf6b35a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.20949$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.20949$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18993396$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17570510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prasad, H. Keshava</creatorcontrib><creatorcontrib>Kaushal, Varsha</creatorcontrib><creatorcontrib>Mehta, Paulette</creatorcontrib><title>Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: Case report and review of literature</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><description>Thalidomide is being increasingly used in hematology and oncology. Its use is associated with neuropathy, sedation, edema, fatigue, constipation, and deep venous thrombosis. Cytopenias are unusual, but there are case reports. However, there are no reports of isolated thrombocytopenia. We describe here a case of prolonged isolated thrombocytopenia most likely caused by thalidomide. The patient's in platelet count decreased promptly after an increase in the dose and improved after discontinuation of the drug. The relevant literature is reviewed. Am. J. Hematol., 2007. © 2007 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Drug</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - blood</subject><subject>Multiple Myeloma - drug therapy</subject><subject>Platelet Count</subject><subject>Platelet diseases and coagulopathies</subject><subject>Thalidomide - adverse effects</subject><subject>Thrombocytopenia - chemically induced</subject><subject>Treatment Outcome</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MFu3CAQBmBUNWq2aQ95gYhLDz1sMhjsNblFq7ZJFSmX5GyNYawlwsYCNiu_fWl3pZx64hfziRE_Y5cCrgVAdYOvu-sKtNIf2EqAbtZtU1cf2QpkI0oGfc4-p_QKIIRq4RM7F5t6A7WAFVseUvCYyfK8i2Hsg1lymGlyyN1k96YM-qXM0DsbRmepXHPkM2ZHU-YHl3d83PvsZk98XMiHEW_5FhPxSHOImeNkS3xzdOBh4N5lipj3kb6wswF9oq-n84K9_PzxvL1fPz79etjePa6NBKnXFnoSSpVfqXZoba0rog2CHUAqtVGqspaQDAHVsi20IqOGEs3Q9LJGIS_Y9-O7JoaUIg3dHN2IcekEdH_r60p93b_6ir062nnfj2Tf5amvAr6dACaDfog4GZfeXau1lLop7uboDs7T8v-N3d3v--PqPw-CiSE</recordid><startdate>200709</startdate><enddate>200709</enddate><creator>Prasad, H. Keshava</creator><creator>Kaushal, Varsha</creator><creator>Mehta, Paulette</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200709</creationdate><title>Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: Case report and review of literature</title><author>Prasad, H. Keshava ; Kaushal, Varsha ; Mehta, Paulette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3039-d0be14409648f8d592ee7a0df03447442ddeaece0e538be12ec4f538cf6b35a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Drug</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - blood</topic><topic>Multiple Myeloma - drug therapy</topic><topic>Platelet Count</topic><topic>Platelet diseases and coagulopathies</topic><topic>Thalidomide - adverse effects</topic><topic>Thrombocytopenia - chemically induced</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prasad, H. Keshava</creatorcontrib><creatorcontrib>Kaushal, Varsha</creatorcontrib><creatorcontrib>Mehta, Paulette</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prasad, H. Keshava</au><au>Kaushal, Varsha</au><au>Mehta, Paulette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: Case report and review of literature</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2007-09</date><risdate>2007</risdate><volume>82</volume><issue>9</issue><spage>855</spage><epage>857</epage><pages>855-857</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><coden>AJHEDD</coden><abstract>Thalidomide is being increasingly used in hematology and oncology. Its use is associated with neuropathy, sedation, edema, fatigue, constipation, and deep venous thrombosis. Cytopenias are unusual, but there are case reports. However, there are no reports of isolated thrombocytopenia. We describe here a case of prolonged isolated thrombocytopenia most likely caused by thalidomide. The patient's in platelet count decreased promptly after an increase in the dose and improved after discontinuation of the drug. The relevant literature is reviewed. Am. J. Hematol., 2007. © 2007 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17570510</pmid><doi>10.1002/ajh.20949</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof American journal of hematology, 2007-09, Vol.82 (9), p.855-857
issn 0361-8609
1096-8652
language eng
recordid cdi_crossref_primary_10_1002_ajh_20949
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Wiley Free Content
subjects Biological and medical sciences
Dose-Response Relationship, Drug
Hematologic and hematopoietic diseases
Humans
Immunodeficiencies. Immunoglobulinopathies
Immunoglobulinopathies
Immunopathology
Medical sciences
Middle Aged
Multiple Myeloma - blood
Multiple Myeloma - drug therapy
Platelet Count
Platelet diseases and coagulopathies
Thalidomide - adverse effects
Thrombocytopenia - chemically induced
Treatment Outcome
title Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: Case report and review of literature
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T05%3A09%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isolated%20thrombocytopenia%20induced%20by%20thalidomide%20in%20a%20patient%20with%20multiple%20myeloma:%20Case%20report%20and%20review%20of%20literature&rft.jtitle=American%20journal%20of%20hematology&rft.au=Prasad,%20H.%20Keshava&rft.date=2007-09&rft.volume=82&rft.issue=9&rft.spage=855&rft.epage=857&rft.pages=855-857&rft.issn=0361-8609&rft.eissn=1096-8652&rft.coden=AJHEDD&rft_id=info:doi/10.1002/ajh.20949&rft_dat=%3Cwiley_cross%3EAJH20949%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17570510&rfr_iscdi=true